461 related articles for article (PubMed ID: 26581145)
1. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
Elsayad K; Kriz J; Moustakis C; Scobioala S; Reinartz G; Haverkamp U; Willich N; Weishaupt C; Stadler R; Sunderkötter C; Eich HT
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1077-86. PubMed ID: 26581145
[TBL] [Abstract][Full Text] [Related]
2. Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: an open clinical study and pooled data analysis.
Kamstrup MR; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):138-43. PubMed ID: 25863761
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma.
Thomas TO; Agrawal P; Guitart J; Rosen ST; Rademaker AW; Querfeld C; Hayes JP; Kuzel TM; Mittal BB
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):747-53. PubMed ID: 22818412
[TBL] [Abstract][Full Text] [Related]
4. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
6. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
[TBL] [Abstract][Full Text] [Related]
7. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
[TBL] [Abstract][Full Text] [Related]
8. Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy.
Klein RS; Dunlop JD; Samimi SS; Morrissey KA; Evans KG; Gardner JM; Introcaso CE; Vittorio CC; Rook AH; Micaily B; Kim EJ
J Am Acad Dermatol; 2013 Jun; 68(6):972-7. PubMed ID: 23415461
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation.
Maingon P; Truc G; Dalac S; Barillot I; Lambert D; Petrella T; Naudy S; Horiot JC
Radiother Oncol; 2000 Jan; 54(1):73-8. PubMed ID: 10719702
[TBL] [Abstract][Full Text] [Related]
10. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract][Full Text] [Related]
11. Results of a 5-week schedule of modern total skin electron beam radiation therapy.
Morris SL; McGovern M; Bayne S; Wain M; Child F; Whittaker S
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):936-41. PubMed ID: 23755924
[TBL] [Abstract][Full Text] [Related]
12. The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.
Morris S; Scarisbrick J; Frew J; Irwin C; Grieve R; Humber C; Kuciejewska A; Bayne S; Weatherhead S; Child F; Wain M; Whittaker S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):627-633. PubMed ID: 28843374
[TBL] [Abstract][Full Text] [Related]
13. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
[TBL] [Abstract][Full Text] [Related]
14. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
[TBL] [Abstract][Full Text] [Related]
15. Revisiting low-dose total skin electron beam therapy in mycosis fungoides.
Harrison C; Young J; Navi D; Riaz N; Lingala B; Kim Y; Hoppe R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e651-7. PubMed ID: 21489711
[TBL] [Abstract][Full Text] [Related]
16. Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.
Kamstrup MR; Lindahl LM; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Br J Dermatol; 2012 Feb; 166(2):399-404. PubMed ID: 21967035
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
19. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sézary syndrome).
Jones GW; Rosenthal D; Wilson LD
Cancer; 1999 May; 85(9):1985-95. PubMed ID: 10223240
[TBL] [Abstract][Full Text] [Related]
20. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
Elsayad K; Susek KH; Eich HT
Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
